Urinary Tract Infection (UTI) and Antibiotic Resistance Panel

This qPCR panel tests urine samples and can detect the presence of 17 bacteria and 36 antibiotic resistance genes down to low colony-forming unit (cfu) numbers that culturing is unable to detect.

Results are formatted in an easy-to-read report that helps guide the physician in treating their patient for a urinary tract infection. Based on the presence of bacteria and antibiotic resistance genes in a patient’s sample, it can be determined which antibiotics are likely to be effective or ineffective in treating the infection. An absence of detection does not imply the absence of microorganisms other than those listed, however, and does not exclude the possibility that the target sequence is present below the limit of detection.

The UTI Diagnostic Report does not take into consideration patient history, drug-drug interactions, drug sensitivity, and/or allergies. It is the responsibility of the physician to determine appropriate drug and dosing choices based on all available data.

Specimen Requirements: Minimum of 2 mL of urine from patient, provided in a sterile urine collection container.

Bacterial Pathogens:

  • Acinetobacter baumannii

  • Citrobacter freundii

  • Enterobacter cloacae

  • Enterococcus faecalis

  • Enterococcus faecium

  • Escherichia Coli

  • Klebsiella (Enterobacter) aerogenes

  • Klebsiella oxytoca

  • Klebsiella pneumoniae

  • Morganella morganii

  • Proteus mirabilis

  • Proteus vulgaris

  • Providencia stuartii

  • Pseudomonas aeruginosa

  • Staphylococcus saprophyticus

  • Streptococcus agalactiae

Fungus:

  • Candida albicans

Resistance Genes:

  • Ampicillin Resistance

  • Carbapenem Resistance

  • Extended Spectrum Beta-lactamase

  • Fosfomycin ResistanceMacrolide Resistance

  • Quinolone & Fluoroquinolone Resistance

  • Sulfonamide Resistance

  • Tetracycline Resistance

  • Trimethoprim Resistance

  • Vancomycin Resistance

We offer comprehensive UTI testing panels that not only detect common pathogens, but also provide crucial information on antibiotic resistance, empowering clinicians with the data they need to make informed treatment decisions and combat antibiotic resistance effectively.

Indications for Molecular UTI Panel

  • Recurring UTIs

  • Interstitial Cystitis

  • Pyelonephritis

  • Immunocompromised Patients

  • Over 50 years of age

  • Chronic Pain Patients

  • Pregnancy

Turnaround time is 24-72 hours